Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 13 Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships in Belfast
Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships in Belfast
We have 13 Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships in Belfast
PhD students in Pharmaceutical Chemistry research a range of chemical compounds and their impact on human health. You could be examining the design, synthesis, and evaluation of therapeutics or working on leading-edge research into infectious diseases and antimicrobial resistance.
What's it like to study a PhD in Pharmaceutical Chemistry?
With a PhD in Pharmaceutical Chemistry, you'll have the opportunity to build your own unique research portfolio. You could be focusing on the development of therapeutics, drug delivery systems and vaccines, or using cutting-edge techniques such as mass spectrometry to study disease.
Possible research areas include:
- Pharmaceutical analysis
- Pharmacology
- Pharmaceutical research and development
- Pharmacokinetics and pharmacodynamics
- Biopharmacy and biotherapeutics
You'll take part in research rotations to gain expertise in certain areas of Pharmaceutical Chemistry. You will have the opportunity to collaborate with local hospitals and connect with the wider scientific community through attending conferences and publishing papers.
Most PhD programmes in Pharmaceutical Chemistry last 3-4 years. Your project may have a research training component, which connects you with the wider aim of your department and university. You will submit an approximately 80,000-word thesis to be defended at the end of your study.
PhD in Pharmaceutical Chemistry entry requirements
The minimum entry requirement for a PhD in Pharmaceutical Chemistry is usually a 2:1 undergraduate degree in a relevant subject, although a Masters may occasionally be required.
Some PhDs in Pharmaceutical Chemistry may ask you to express an interest in certain research areas.
PhD in Pharmaceutical Chemistry funding options
In the UK, PhDs in Pharmaceutical Chemistry can be funded by the Medical Research Council (MRC), which provides a tuition fee waiver and a living cost stipend.
You may have to self-fund in which case you can look at government loans, university scholarships and charities and trusts for funding.
PhD in Pharmaceutical Chemistry careers
There are many career options for graduates with a PhD in Pharmaceutical Chemistry. You could take up a postdoctoral position at a university or pharmaceutical company, or you might decide to apply your scientific knowledge through roles in regulatory affairs.
PhD saved successfully
3D-Printing of implantable devices for the treatment of chronic conditions
Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more
Microneedle delivery systems for next-generation antibody therapeutics
Microneedle arrays are minimally-invasive devices that painlessly, and without drawing blood, penetrate the skin’s stratum corneum barrier. Read more
Structure-based design of allosteric modulators for G protein-coupled receptors using molecular modelling and pharmacology experiments
Almost all physiological processes are regulated through the activation of G protein-coupled receptors (GPCRs). It has become widely accepted that most GPCRs possess binding sites spatially distinct from their natural ligand binding site (orthosteric site), termed as allosteric sites. Read more
Dissecting mechanism of drug responses to novel anti-cancer therapies
Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more
Strategies and key technologies to produce amorphous solid dispersions
Poor drug solubility presents a major challenge in drug product development of oral solid dosage (OSD) forms. However, many new development compounds exhibit poor solubility and only a few of them reach market approval. Read more
Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implants
One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more
Dexamethasone-releasing cochlear implants for fibroblast growth inhibition
Cochlear implants are implanted electronic hearing device designed to produce useful hearing sensations to persons with severe to profound nerve deafness by electrically stimulating nerves inside the inner ear. Read more
Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways
The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more
Chemical glycoengineering of therapeutic antibodies
Glycosylation is the most common posttranslational protein modification. Recombinant therapeutic glycoproteins (RTGs) such as monoclonal antibodies (mAbs) are decorated with complex glycans that determine not only their efficacy but also other critical parameters such as in vivo half-life, stability and antigenicity. Read more
Bio-inspired liquid-like coatings for medical devices to combat biofilms and associated infections
Biofilms are microbial cells embedded within a self-secreted extracellular polymeric substance matrix, which are central to some of the most urgent global challenges across diverse fields of application, from medicine to industry and exert considerable economic and social impact. Read more
MICROFLUIDIC TECHNOLOGIES FOR THE PRODUCTION OF NANOMEDICINES
Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge. Read more
Polymer-engineering nanocages for protein delivery
Protein therapeutics are a fast-acting and potent class of medicine with remarkable success in the treatment of several relevant disorders. Read more
Advanced manufacturing of paediatric formulations with poorly water soluble drugs
This project employs an advanced manufacturing technique, microwave-induced in situ amorphization, in combination with a wide range of characterization techniques to tackle the consistent stability issue of amorphous solid dispersions as a means of improving the dissolution performance of paediatric personalised formulations with poorly water soluble drugs. Read more
- 1